Baidu
map

A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

Aghajanian, C; Filiaci, V; Dizon, DS; Carlson, JW; Powell, MA; Secord, AA; Tewari, KS; Bender, DP; O'Malley, DM; Stuckey, A; Gao, JJ; Dao, F; Soslow, RA; Lankes, HA; Moore, K; Levine, DA

Aghajanian, C (reprint author), Mem Sloan Kettering Canc Ctr, Gynecol Med Oncol Serv, 300 East 66th St, New York, NY 10065 USA.

GYNECOLOGIC ONCOLOGY, 2018; 150 (2): 274

Abstract

Objective. Paclitaxel and carboplatin (PC) is a standard initial therapy for advanced endometrial cancer. We evaluated the efficacy and tolerability o......

Full Text Link


Baidu
map
Baidu
map
Baidu
map